Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Total 13F shares
-
2,207,792
-
Share change
-
-191,307
-
Total reported value
-
$4,170,727
-
Put/Call ratio
-
20%
-
Price per share
-
$1.89
-
Number of holders
-
20
-
Value change
-
-$310,716
-
Number of buys
-
4
-
Number of sells
-
11
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2023
As of 30 Sep 2023 CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,207,792 shares of stock of the company.
Largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, STATE STREET CORP, and TWO SIGMA INVESTMENTS, LP.
This table shows 20 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.